Studies on EAE and MS suggest that CC chemokine ligands (most prominently CCL2, CCL3, CCL5, CCL7, CCL8, but also CCL1, CCL4, CCL19 and CCL21) expressed by residential immune cells in the CNS or by endothelial cells at the BBB are major chemoattractants for hematogenic immune cells (primarily monocytes / macrophages [CCL2, CCL7, CCL8, CCL22] dendritic cells [CCL19, CCL20, CCL21, CCL22] and T lymphocytes [CCL1, CCL2, CCL3, CCL4, CCL5, CCL19, CCL21, CCL22]) via interactions with their G-protein-coupled receptors (CCR1-CCR10). Here, CCL7 is linked to myeloid sarcoma.